Table of contents

Influenza Vaccines

• Introduction (1 March, 1973) Free

  Geoffrey C. Schild
• Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation (1 March, 1973) Free

  Steven R. Mostow, Stephen C. Schoenbaum, Walter R. Dowdle, Marion T. Coleman, Harold S. Kaye
• Inactivated vaccines. 2. Laboratory indices of protection (1 March, 1973) Free

  W. R. Dowdle, M. T. Coleman, S. R. Mostow, H. S. Kaye, S. C. Schoenbaum
• Age-related response to 1000 CCA unit zonally purified, inactivated influenza vaccines in volunteers in the U.S.A (1 March, 1973) Free

  William M. Marine, James E. Thomas
• Studies on influenza vaccine in industry (1 March, 1973) Free

  J. W. G. Smith, R. Pollard
• The protective effect of intranasal immunization with inactivated influenza virus vaccine (1 March, 1973) Free

  K. S. Liem, J. Jacobs, E. A. Marcus, R. van Strik
• The potential role of immunological adjuvants in influenza vaccines (1 March, 1973) Free

  Derek Hobson
• A new subunit influenza vaccine: acceptability compared with standard vaccines and antigenicity in increasing dosage (1 March, 1973) Free

  Frederick L. Ruben, George Gee Jackson
• Fractionation of the influenza virus with the object of producing subunit vaccine (1 March, 1973) Free

  L. Hoyle, Sheila M. Barker
• Use of recombination in the production of influenza vaccine strains (1 March, 1973) Free

  D. McCahon, A. S. Beare, G. C. Schild, T. S. Hall
• Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection (1 March, 1973) Free

  D. A. J. Tyrrell, R. A. Buckland, G. C. Schild, D. S. Freestone, S. Chinn, A. N. Slepushkin